Literature DB >> 21482222

MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.

Lifen Wu1, Chunli Cai, Xinghua Wang, Min Liu, Xin Li, Hua Tang.   

Abstract

RAC1 regulates a diverse array of cellular events including migration and invasion. MicroRNAs (miRNAs) have a key role in the regulation of gene expression. In this study, we demonstrated that microRNA-142-3p (miR-142-3p) acted as a negative regulator of human RAC1. Overexpression of miR-142-3p decreased RAC1 mRNA and protein levels. Moreover, the overexpression of miR-142-3p suppressed, while blocking of miR-142-3p increased colony formation, migration and invasion in hepatocellular carcinoma (HCC) cell lines (QGY-7703 and SMMC-7721). RAC1 overexpression without the 3'untranslated region abolished the effect of miR-142-3p in the QGY-7703 and SMMC-7721 cells. These results demonstrated that miR-142-3p directly and negatively regulates RAC1 in HCC cells, which highlights the importance of miRNAs in tumorigenesis.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482222     DOI: 10.1016/j.febslet.2011.03.067

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  69 in total

1.  MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.

Authors:  Felice Ho-Ching Tsang; Sandy Leung-Kuen Au; Lai Wei; Dorothy Ngo-Yin Fan; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

2.  Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.

Authors:  Zhengqiang Wang; Qianshan Ding; Yanxia Li; Qingqing Liu; Wei Wu; Lu Wu; Honggang Yu
Journal:  Tumour Biol       Date:  2016-09-16

Review 3.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

4.  Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.

Authors:  Yi Wang; Zhidong Cao; Lanlan Wang; Siqi Liu; Jianqiang Cai
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

Review 5.  MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.

Authors:  Akiko Matsuda; Irene K Yan; Catherine Foye; Mansi Parasramka; Tushar Patel
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-08-01       Impact factor: 4.690

6.  Human autophagy gene ATG16L1 is post-transcriptionally regulated by MIR142-3p.

Authors:  Zili Zhai; Feng Wu; Fengshi Dong; Alice Y Chuang; Jeannette S Messer; David L Boone; John H Kwon
Journal:  Autophagy       Date:  2014-01-06       Impact factor: 16.016

7.  A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.

Authors:  Silvia Grassilli; Ervin Nika; Elisabetta Lambertini; Federica Brugnoli; Roberta Piva; Silvano Capitani; Valeria Bertagnolo
Journal:  Cell Oncol (Dordr)       Date:  2016-08-01       Impact factor: 6.730

8.  Rac1 functions downstream of miR-142 in regulation of erythropoiesis.

Authors:  Natalia Rivkin; Elik Chapnik; Yehudit Birger; Eran Yanowski; Caterina Curato; Alexander Mildner; Ziv Porat; Gail Amir; Shai Izraeli; Steffen Jung; Eran Hornstein
Journal:  Haematologica       Date:  2017-09-14       Impact factor: 9.941

9.  MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.

Authors:  Peng Xiao; Wen-Liang Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.

Authors:  Siuwah Tang; Jillian Bonaroti; Sebnem Unlu; Xiaoyan Liang; Daolin Tang; Herbert J Zeh; Michael T Lotze
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.